LGND AI, Inc. | $9,000,000 | (Jul 11, 2025)
Cerebrium | $8,500,000 | (Jul 11, 2025)
Bilt | $250,000,000 | (Jul 11, 2025)
Carthera
France
- PARIS, IDF
- 27/06/2023
- Series B
- $41,077,875
Carthera® is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices to treat a wide range of severe brain disorders.
Carthera® has developed a proprietary device called SonoCloud®- a groundbreaking medical device that emits ultrasound to temporarily increase the permeability of the blood vessels in the brain.
By using SonoCloud®, the therapeutic efficacy of new and existing therapies can be unlocked and harnessed to improve the treatment of a wide range of brain diseases: oncology indications (glioblastoma, brain metastasis) or neurodegenerative diseases (such as Alzheimer’s Disease, ALS).
The products developed by Carthera® are in clinical or preclinical evaluation (not FDA or CE approved) and are not available for sale.
- Industry Medical Equipment Manufacturing
- Website https://carthera.eu/
- LinkedIn https://www.linkedin.com/company/carthera/
Aqtual, Inc. | $31,000,000 | (Jul 11, 2025)
Knox Systems, Inc. | $6,500,000 | (Jul 11, 2025)
Live Story | $3,154,279 | (Jul 11, 2025)
Spacelift | $51,000,000 | (Jul 11, 2025)
Foundation EGI | $23,000,000 | (Jul 11, 2025)
Augmentus Robotics | $11,000,000 | (Jul 11, 2025)
Datafy.io | $20,000,000 | (Jul 11, 2025)
Renasant Bio | $54,500,000 | (Jul 11, 2025)
Supply Wisdom | $14,000,000 | (Jul 10, 2025)